South Africa Anti-Infective Market
The South Africa Anti-Infective Market size was valued at US$ 1,893.5 Mn in 2018 and is projected to reach US$ 2,572.5 Mn by 2027, growing at a CAGR of 3.6% during 2019 - 2027.
Report Coverage
- Type: Antibacterial, Antiviral and Antifungal
- Range: Broad Spectrum, Narrow Spectrum
- Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
US$ 1,893.5 Mn
Market size in 2018
US$ 2,572.5 Mn
Market Size by 2027
3.6%
CAGR, 2019 - 2027
2019-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South Africa Anti-Infective Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South Africa Anti-Infective Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South Africa Anti-Infective Market Regional Analysis
6.2 South Africa Anti-Infective Market Revenue 2016-2027 (US$ Million)
6.3 South Africa Anti-Infective Market Forecast Analysis
7. South Africa Anti-Infective Market Analysis – by Type
7.1 Antibacterial
- 7.1.1 Overview
- 7.1.2 Antibacterial: South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Antiviral and Antifungal
- 7.2.1 Overview
- 7.2.2 Antiviral and Antifungal: South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. South Africa Anti-Infective Market Analysis – by Range
8.1 Broad Spectrum
- 8.1.1 Overview
- 8.1.2 Broad Spectrum: South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Narrow Spectrum
- 8.2.1 Overview
- 8.2.2 Narrow Spectrum: South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. South Africa Anti-Infective Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.3 Mail Order Pharmacies
- 9.3.1 Overview
- 9.3.2 Mail Order Pharmacies : South Africa Anti-Infective Market – Revenue and Forecast, 2016-2027 (US$ Million)
10. South Africa Anti-Infective Market – South Africa Analysis
10.1 Overview
10.2 South Africa- 10.2.1 South Africa Anti-Infective Market Breakdown, by Key Country, 2019 and 2027 (%)
- 10.2.1.1 South Africa Anti-Infective Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 South Africa: South Africa Anti-Infective Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 South Africa: South Africa Anti-Infective Market Breakdown, by Type
- 10.2.1.1.2 South Africa: South Africa Anti-Infective Market Breakdown, by Range
- 10.2.1.1.3 South Africa: South Africa Anti-Infective Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Sanofi
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Abbott
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Pfizer Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Merck & Co. Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bayer AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Johnson & Johnson Services, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Sandoz International GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Aspen Holdings
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Astellas Pharma Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full S Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
